ABSTRACT
Data collection process
10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
Data items
11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
5
Risk of bias in individual studies 12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
5-6
Section/topic # Checklist item Reported on page # bias, selective reporting within studies). 7
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, metaregression), if done, indicating which were pre-specified.
NA

RESULTS
Study selection
17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
6
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations. consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
12
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
17
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.
12-17
FUNDING
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data);
role of funders for the systematic review. √ Assessment of quality of included studies Study quality was assessed using the Cochrane risk of bias tool.
Reporting of conclusions should include
√
Consideration of alternative explanations for observed results
We discussed that multiple testing might be a potential alternative explanation for the observed results, as not all studies corrected for this.
√
Generalization of the conclusions
The generalizability of our findings has been limited by the small sample sizes of the included trials. Also, the findings are not generalizable to children as the included trials only comprised the adult population. 
